Key figures about IFE

650 employees from 38 different countries

1 billion in annual turnover

25 advanced laboratories

130 scientific publications

> 200 international projects

Short about IFE

IFE, Institute for Energy Technology, researches for a better future.

Since 1948, we have been a frontrunner in international energy research. The knowledge we have developed has saved the petroleum industry several hundred billion Norwegian kroner. We have contributed to the development of ground-breaking cancer medicine, new solutions in renewable energy, more energy-efficient industrial processes, zero-emission transport solutions and future-oriented energy systems.

Our research reactors have led to better nuclear safety in our neighboring countries and around the world, and were also key in leading research on energy and materials in Norway. The reactor operations were terminated in 2018-2019, and IFE’s nuclear activities are currently in a transition phase, preparing for decommissioning.

IFE holds a license to own and operate nuclear plants and fuel storage facilities in Halden and Kjeller until 31 December 2028. The government agency Norwegian nuclear decommissioning (NND) will take over the license for the reactors and nuclear facilities to be decommissioned at a point before the IFE license period expires, with target date 1.1.2024.

At IFE, we build bridges between research, education and industry. We have extensive infrastructure and full-scale laboratories where theoretical models are transformed into commercial activities. IFE has unique expertise and systems within radiation protection and environmental monitoring of radioactive and chemical emissions. This makes us an important partner for companies that want to research, develop and produce new solutions for renewable energy and medicine using radioactive sources.

The digitalization of society is seeing the emergence of a new era. IFE has broad digital expertise and contributes to quality assurance and efficiency improvements for customers in the public sector and in trade and industry. When the next chapter in Norway’s history is written, it will be about how we adapt. We must create new and sustainable jobs. At IFE we have already begun – we are conducting research for a better future.

Reporting wrongdoing or concerns

Information to our partners

IFE aims to ensure there are no barriers to reporting wrongdoing, i.e., whistleblowing. The institute, our employees and partners all benefit from a healthy corporate culture and positive collaborations. We will ensure that any challenges will be addressed when they arise and will try to do this within the same level of the organisation where they arise.

It is preferable that whistleblowing takes place openly by a named person as this enables the circumstances of the matter to be properly investigated. The identity of the whistleblower will remain confidential. However, whistleblowing can be done anonymously.

Our partners can use two whistleblowing channels:

  • If you wish to use IFE’s internal whistleblowing channel, you can send an email to
  • Our external whistleblowing channel is managed by the Grette law firm, and the following email can be used:

Employees can find further details of whistleblowing on our intranet, in the Ethics portal.

Whistleblowers can also report wrongdoing to a public supervisory authority or another public authority. Whistleblowing to the media should only take place if reporting the matter internally has failed to resolve the issue or if there is reason to believe that internal whistleblowing would not be appropriate.

IFE’s Code of Conduct can be found as pdf file below.

IFE's main tasks

  • Develop profitable, safe and environmentally friendly technologies in renewable energy, petroleum extraction and CO2 handling and usage (CCSU)
  • Offer IFE's unique expertise in VR, AR, digitalization and nuclear safety technology to other industries and government agencies
  • Maintain and further develop national nuclear expertise with focus on decommissioning reactors
  • Advanced materials research using neutron materials characterization as the main tool
  • Safeguard and further develop the production of groundbreaking cancer medicine and other nuclear medicine